OLEMA PHARMACEUTICALS INC's ticker is OLMA and the CUSIP is 68062P106. A total of 97 filers reported holding OLEMA PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.23 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,904,424 | -75.3% | 235,176 | -82.0% | 0.48% | -70.7% |
Q2 2023 | $11,778,118 | +68.7% | 1,304,332 | -35.2% | 1.62% | +79.8% |
Q1 2023 | $6,981,130 | +40.7% | 2,011,853 | -0.7% | 0.90% | +18.4% |
Q4 2022 | $4,961,823 | +28.4% | 2,025,234 | +44.7% | 0.76% | -6.5% |
Q3 2022 | $3,863,000 | +281.0% | 1,399,633 | +461.6% | 0.81% | +214.3% |
Q2 2022 | $1,014,000 | -15.2% | 249,229 | -11.3% | 0.26% | -33.2% |
Q1 2022 | $1,196,000 | -56.5% | 280,827 | -4.4% | 0.39% | -73.6% |
Q4 2021 | $2,750,000 | – | 293,799 | – | 1.47% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Logos Global Management LP | 3,743,875 | $15,238,000 | 2.80% |
Fairmount Funds Management LLC | 2,669,300 | $10,864,000 | 2.49% |
BVF INC/IL | 7,611,503 | $30,979,000 | 1.50% |
Vivo Capital, LLC | 1,689,515 | $6,876,000 | 0.69% |
Cormorant Asset Management, LP | 2,082,000 | $8,474,000 | 0.64% |
Newtyn Management, LLC | 500,000 | $2,035,000 | 0.39% |
Kynam Capital Management, LP | 249,229 | $1,014,000 | 0.26% |
Monaco Asset Management SAM | 130,000 | $529,000 | 0.23% |
TANG CAPITAL MANAGEMENT LLC | 318,926 | $1,298,000 | 0.20% |
Artal Group S.A. | 260,500 | $1,060,000 | 0.06% |